Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 8.16
+0.03 (0.37%)
Sep 17, 2026, 4:10 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 411.49 million as of September 16, 2026. Its market cap has decreased by -26.96% in one year.
Market Cap
411.49M
Enterprise Value
161.37M
Revenue
94.02M
Ranking
n/a
PE Ratio
12.22
Stock Price
8.16
ChartMarket Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 411.49M, an increase of 7,774.43%. That is a compound annual growth rate of 18.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 411.49M | -34.21% |
| Dec 31, 2025 | 625.50M | 3.84% |
| Dec 31, 2024 | 602.36M | -24.90% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 817.05M |
| Racura Oncology | 392.14M |
| Starpharma Holdings | 355.25M |
| Tetratherix | 336.39M |
| BLS Pharmaceuticals | 268.30M |
| Actinogen Medical | 223.16M |
| Orthocell | 196.08M |
| Nyrada | 179.14M |